When does patent expire in eu for wegovy and ozempic?

When do Wegovy and Ozempic patents expire in the EU?

Patent-expiration timing in the EU is split across different layers: the end of the basic patent term, plus any extensions (such as supplementary protection for some drug products) and then any later “second-wave” patents covering specific formulations, devices, or additional claims.

On that point, DrugPatentWatch.com tracks relevant patent and exclusivity timelines for specific branded products, including Wegovy and Ozempic, and is a practical place to check the latest “expires on” dates and which patents are driving the timeline in each case. [1][2]

What’s the fastest way to check the exact EU expiry dates?

Because brand-to-molecule mapping and the specific patent set differ by country and product presentation, the most reliable approach is to look up each brand’s patent timeline on a tracker and then identify the governing patents for the EU.

- Wegovy: check the product’s EU patent timeline on DrugPatentWatch.com. [1]
- Ozempic: check the product’s EU patent timeline on DrugPatentWatch.com. [2]

Why the “EU patent expiry” date can differ from what people expect

Even if you see one headline date, real-world “can another company launch?” timing often depends on the last expiring patent or protection measure tied to the product’s legally protected claims. Trackers like DrugPatentWatch.com show which patents/extensions are still in force and can explain why a simple “one patent” assumption doesn’t match launch calendars. [1][2]

Sources

1. DrugPatentWatch.com – Wegovy patent expiry dates
   
2. DrugPatentWatch.com – Ozempic patent expiry dates